Multiple molecular mechanisms for multidrug resistance transporters

The acquisition of multidrug resistance is a serious impediment to improved healthcare. Multidrug resistance is most frequently due to active transporters that pump a broad spectrum of chemically distinct, cytotoxic molecules out of cells, including antibiotics, antimalarials, herbicides and cancer chemotherapeutics in humans. The paradigm multidrug transporter, mammalian P-glycoprotein, was identified 30 years ago. Nonetheless, success in overcoming or circumventing multidrug resistance in a clinical setting has been modest. Recent structural and biochemical data for several multidrug transporters now provide mechanistic insights into how they work. Organisms have evolved several elegant solutions to ridding the cell of such cytotoxic compounds. Answers are emerging to questions such as how multispecificity for different drugs is achieved, why multidrug resistance arises so readily, and what chance there is of devising a clinical solution.

[1]  C. Higgins,et al.  The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein. , 2001, Biochemistry.

[2]  Jinhui Dong,et al.  Structural Basis of Energy Transduction in the Transport Cycle of MsbA , 2005, Science.

[3]  K. Diederichs,et al.  Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump Mechanism , 2006, Science.

[4]  J. Taipale,et al.  Hedgehog-Mediated Patterning of the Mammalian Embryo Requires Transporter-like Function of Dispatched , 2002, Cell.

[5]  C. Higgins,et al.  A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene , 1998, Nature.

[6]  Gerry McDermott,et al.  Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump , 2003, Science.

[7]  H. Rosenberg,et al.  Intronic Enhancer Activity of the Eosinophil-derived Neurotoxin (RNS2) and Eosinophil Cationic Protein (RNS3) Genes Is Mediated by an NFAT-1 Consensus Binding Sequence* , 1997, The Journal of Biological Chemistry.

[8]  S. Cole,et al.  Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. , 1998, Cancer research.

[9]  R. Brennan,et al.  Structural Basis of Multidrug Recognition by BmrR, a Transcription Activator of a Multidrug Transporter , 1999, Cell.

[10]  D. Keppler,et al.  Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane , 2003, Hepatology.

[11]  Satoshi Murakami,et al.  Crystal structure of bacterial multidrug efflux transporter AcrB , 2002, Nature.

[12]  S. Schuldiner,et al.  EmrE, the smallest ion-coupled transporter, provides a unique paradigm for structure-function studies. , 1997, The Journal of experimental biology.

[13]  A. Schinkel,et al.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. , 1996, The Journal of clinical investigation.

[14]  C. Higgins,et al.  Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.

[15]  C. B. Roth,et al.  Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. , 2001, Science.

[16]  K. Linton,et al.  An atomic detail model for the human ATP binding cassette transporter P‐glycoprotein derived from disulphide cross‐ linking and homology modeling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  J. Cupp-Vickery,et al.  Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Chang,et al.  Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[20]  John F Hunt,et al.  ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. , 2002, Molecular cell.

[21]  N. Vázquez-Laslop,et al.  Mechanism of ligand recognition by BmrR, the multidrug-responding transcriptional regulator: mutational analysis of the ligand-binding site. , 1999, Biochemistry.

[22]  D. Clarke,et al.  Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug Efflux , 2005, The Journal of Membrane Biology.

[23]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[24]  Colin Hughes,et al.  Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export , 2000, Nature.

[25]  O. Lewinson,et al.  Evidence for simultaneous binding of dissimilar substrates by the Escherichia coli multidrug transporter MdfA. , 2001, Biochemistry.

[26]  L. Moore,et al.  The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.

[27]  D. Clarke,et al.  The Packing of the Transmembrane Segments of Human Multidrug Resistance P-glycoprotein Is Revealed by Disulfide Cross-linking Analysis* , 2000, The Journal of Biological Chemistry.

[28]  Paola Vergani,et al.  CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains , 2005, Nature.

[29]  M. R. Lugo,et al.  Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs. , 2005, Biochemistry.

[30]  G N Murshudov,et al.  The structural basis of sequence-independent peptide binding by OppA protein. , 1994, Science.

[31]  C. Higgins,et al.  Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding* , 2003, The Journal of Biological Chemistry.

[32]  K. Linton,et al.  Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle , 2001, The EMBO journal.

[33]  S. Cole,et al.  Role of Carboxylate Residues Adjacent to the Conserved Core Walker B Motifs in the Catalytic Cycle of Multidrug Resistance Protein 1 (ABCC1)* , 2003, Journal of Biological Chemistry.

[34]  Clifford A Goudey,et al.  Aquaculture in Offshore Zones , 2006, Science.

[35]  K. Linton,et al.  The ATP switch model for ABC transporters , 2004, Nature Structural &Molecular Biology.

[36]  S. Schuldiner,et al.  On Parallel and Antiparallel Topology of a Homodimeric Multidrug Transporter* , 2006, Journal of Biological Chemistry.

[37]  S. Iwata,et al.  Structure and Mechanism of the Lactose Permease of Escherichia coli , 2003, Science.

[38]  G. Chang,et al.  Structure of the Multidrug Transporter EmrD from Escherichia coli , 2006, Science.

[39]  PETER MITCHELL,et al.  A General Theory of Membrane Transport From Studies of Bacteria , 1957, Nature.

[40]  M H Saier,et al.  Phylogeny of multidrug transporters. , 2001, Seminars in cell & developmental biology.

[41]  C. Higgins,et al.  Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis. , 2000, Biochemistry.

[42]  S. Taylor,et al.  Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated , 1995, Journal of bacteriology.

[43]  M. Schumacher,et al.  Structural Mechanisms of QacR Induction and Multidrug Recognition , 2001, Science.

[44]  Douglas C. Rees,et al.  The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.

[45]  H. Nikaido,et al.  Aminoglycosides Are Captured from both Periplasm and Cytoplasm by the AcrD Multidrug Efflux Transporter of Escherichia coli , 2005, Journal of bacteriology.

[46]  O. Lewinson,et al.  Alkalitolerance: a biological function for a multidrug transporter in pH homeostasis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  I. Pastan,et al.  Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Neyfakh.  Mystery of multidrug transporters: the answer can be simple , 2002, Molecular microbiology.

[49]  C. Higgins,et al.  The homodimeric ATP‐binding cassette transporter LmrA mediates multidrug transport by an alternating two‐site (two‐cylinder engine) mechanism , 2000, The EMBO journal.

[50]  E. Bibi,et al.  Promiscuity in the Geometry of Electrostatic Interactions between the Escherichia coli Multidrug Resistance Transporter MdfA and Cationic Substrates* , 2005, Journal of Biological Chemistry.

[51]  D. Rees,et al.  An Inward-Facing Conformation of a Putative Metal-Chelate-Type ABC Transporter , 2007, Science.

[52]  Karl Kuchler,et al.  ABC proteins : from bacteria to man , 2003 .

[53]  S. Schuldiner,et al.  A model for coupling of H(+) and substrate fluxes based on "time-sharing" of a common binding site. , 2000, Biochemistry.

[54]  H. Nikaido,et al.  Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Keppler,et al.  cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.

[56]  C. Cambillau,et al.  The Insect Attractant 1-Octen-3-ol Is the Natural Ligand of Bovine Odorant-binding Protein* , 2001, The Journal of Biological Chemistry.

[57]  M. Schumacher,et al.  Structural mechanism of the simultaneous binding of two drugs to a multidrug‐binding protein , 2004, The EMBO journal.

[58]  S. Schuldiner,et al.  Exploring the Binding Domain of EmrE, the Smallest Multidrug Transporter* , 2005, Journal of Biological Chemistry.

[59]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[60]  P. Borst,et al.  Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.

[61]  J. Schellens,et al.  Evidence for Two Interacting Ligand Binding Sites in Human Multidrug Resistance Protein 2 (ATP Binding Cassette C2)* , 2003, Journal of Biological Chemistry.

[62]  M. Scott,et al.  Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events. , 2001, Molecular biology of the cell.

[63]  Gunnar von Heijne,et al.  Identification and evolution of dual-topology membrane proteins , 2006, Nature Structural &Molecular Biology.

[64]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[65]  Satoshi Murakami,et al.  Crystal structures of a multidrug transporter reveal a functionally rotating mechanism , 2006, Nature.

[66]  Christopher G Tate,et al.  Three‐dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer , 2003, The EMBO journal.

[67]  A. Driessen,et al.  Energetics of wild-type and mutant multidrug resistance secondary transporter LmrP of Lactococcus lactis. , 2004, Biochimica et biophysica acta.

[68]  A. Driessen,et al.  Multidrug resistance in Lactococcus lactis: evidence for ATP‐dependent drug extrusion from the inner leaflet of the cytoplasmic membrane. , 1996, The EMBO journal.

[69]  C. Higgins,et al.  Communication between multiple drug binding sites on P-glycoprotein. , 2000, Molecular pharmacology.

[70]  S. Iwata,et al.  Lactose permease as a paradigm for membrane transport proteins (Review) , 2004, Molecular membrane biology.

[71]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[72]  I. Pastan,et al.  Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. , 1994, Molecular pharmacology.

[73]  V. Ling,et al.  Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. , 1997, European journal of biochemistry.

[74]  M. Putman,et al.  The secondary multidrug transporter LmrP contains multiple drug interaction sites. , 1999, Biochemistry.

[75]  I. J. Evans,et al.  A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria , 1986, Nature.

[76]  C. Higgins,et al.  Three-dimensional Structure of P-glycoprotein , 2005, Journal of Biological Chemistry.